Efficacy and Safety of Crinone Versus Combination Medication (ACCESS)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Infertility
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 20 years and 38 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03858049
- Collaborators
- Merck Serono Co., Ltd.
- Investigators
- Study Director: Medical Responsible Merck KGaA, Darmstadt, Germany
Get Well Soon